Delivery Order SPE2DB20D3505-SPE2DB24FT6P4
Award Date
1/24/24
Potential Completion Date
1/25/24
Potential Value
$1.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,727.36, is for the delivery of ATOMOXETINE HCL 40 MG CAPSULE 30S, a prescription medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an Ultimate Completion Date of December 20, 2024. This contract award is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $1,035.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4564675659 ! ATOMOXETINE HCL 40 MG CAPSULE 30S, a prescription medication. This is a Firm Fixed Price Delivery Order contract with a completion date of May 22, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $3,615.41, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, for the supply of ATOMOXETINE HCL 10 MG CAPSULE 30S, a medication. The award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,391.63, is for the delivery of ATOMOXETINE HCL 40 MG CAPSULE 30S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of July 15, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,432.16 firm fixed-price delivery order is for the supply of 4556432935 ATOMOXETINE HCL 40 MG CAPSULE 30S. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. The company...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,242.67 firm-fixed-price delivery order is for the supply of ATOMOXETINE HCL 10 MG CAPSULES, with a completion date of November 8, 2024. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides delivery orders for the supply of ATOMOXETINE HCL 40 MG CAPSULE 30S to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $2,282.76 and a completion date of September 26, 2024. It is a Firm Fixed Price, Delivery Order contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,332.93 firm fixed-price delivery order is for the supply of 4566771107 - Atomoxetine HCL 40 mg capsules in quantities of 30s. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award, with ID SPE2DB20D2002|SPE2DB25FL21N, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,281.94 firm fixed-price delivery order is for the supply of ATOMOXETINE HCL 40 MG CAPSULE 30S, a type of prescription medication. The contract has an ultimate completion date of February 21, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award, with a ceiling value of $1,126.22, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Atomoxetine HCL 40 mg capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract does not have a set-aside designation, indicating it was open to full and open competition. AmerisourceBergen holds a...